• Source: 5F-AB-PINACA

    • 5F-AB-PINACA is an indazole-based synthetic cannabinoid that is derived from a series of compounds originally developed by Pfizer in 2009 as an analgesic medication, and has been sold online as a designer drug.
    5F-AB-PINACA has been reported to be a potent agonist of the CB1 receptor and CB2 receptor with EC50 values of 0.48 nM and 2.6 nM respectively. Its metabolism has been described in literature.


    Legality




    = China

    =
    As of October 2015 5F-AB-PINACA is a controlled substance in China.


    = Germany

    =
    5F-AB-PINACA is an Anlage II controlled substance in Germany as of May 2015.


    = Singapore

    =
    It is also controlled under the Fifth Schedule of the Misuse of Drugs Act (MDA) in Singapore as of May 2015.


    See also




    References

Kata Kunci Pencarian: